Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Jia Huang1 Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, [email protected]

Yun Wang1 Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, [email protected]

Jun Chen1 Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, [email protected]

Yanlei Zhang2 Medical Department, Eli Lilly and Company, Shanghai, China

Zheng Yuan2 Medical Department, Eli Lilly and Company, Shanghai, China

Li Yue2 Medical Department, Eli Lilly and Company, Shanghai, China

Josep Maria Haro3 Research, Teaching and Innovation Unit, Parc Sanitari Sant Joan De Déu, CIBERSAM, Universitat de Barcelona, Sant Boi De Llobregat, Barcelona, Spain

Maria Victoria Moneta3 Research, Teaching and Innovation Unit, Parc Sanitari Sant Joan De Déu, CIBERSAM, Universitat de Barcelona, Sant Boi De Llobregat, Barcelona, Spain

Diego Novick4 Health Outcomes, Eli Lilly and Company, Windlesham, Surrey, UK

Yiru Fang1 Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, [email protected];5 State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, CAS, Shanghai, China, [email protected];6 Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China, [email protected]Correspondence[email protected]

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Nur Hani Zainal & Michelle G. Newman. (2022) Executive Functioning Constructs in Anxiety, Obsessive–Compulsive, Post-Traumatic Stress, and Related Disorders. Current Psychiatry Reports 24:12, pages 871-880.
Crossref

Gami L. Nanayakkara, Lena Krincic, Rhonda Lightfoot, Wendy Reinhardt, Keshani De Silva, Janek M. Senaratne & Manohara P. J. Senaratne. (2022) Demographics and risk factors that influence the prevalence of depression in patients attending cardiac rehabilitation. Medicine 101:36, pages e30470.
Crossref

Victor Puac-Polanco, Hannah N. Ziobrowski, Eric L. Ross, Howard Liu, Brett Turner, Ruifeng Cui, Lucinda B. Leung, Robert M. Bossarte, Corey Bryant, Jutta Joormann, Andrew A. Nierenberg, David W. Oslin, Wilfred R. Pigeon, Edward P. Post, Nur Hani Zainal, Alan M. Zaslavsky, Jose R. Zubizarreta, Alex Luedtke, Chris J. Kennedy, Andrea Cipriani, Toshiaki A. Furukawa & Ronald C. Kessler. (2022) Development of a model to predict antidepressant treatment response for depression among Veterans. Psychological Medicine, pages 1-11.
Crossref

Jian Huang, Han-Han Kong, Si-Jia Li, Rui-Jin Zhang, Hao-Dong Qian, Dan-Ran Li, Jin-Yu He, Yi-Nuo Zheng & Hao Xu. (2021) Asymmetric copper-catalyzed propargylic amination with amine hydrochloride salts. Chemical Communications 57:38, pages 4674-4677.
Crossref

Mostafa Farajollahi-Moghadam, Hossein Sanjari-Moghaddam, Maryam Ghazizadeh Hasemi, Zahra Sanatian, Ali Talaei & Shahin Akhondzadeh. (2021) Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial. International Clinical Psychopharmacology 36:3, pages 140-146.
Crossref

Mir Hilal Ahmad, M. Moshahid Alam Rizvi, Mahino Fatima & Amal Chandra Mondal. 2021. The Neuroscience of Depression. The Neuroscience of Depression 341 350 .

Maria Rosaria Anna Muscatello, Rocco A. Zoccali, Gianluca Pandolfo, Paolo Mangano, Simona Lorusso, Clemente Cedro, Fortunato Battaglia, Edoardo Spina & Antonio Bruno. (2019) Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder. Frontiers in Psychiatry 10.
Crossref

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date